SINGAPORE (ICIS)–Evonik is ramping up plant and research investments in Asia to hit their growth targets, while mitigating direct shocks from US tariffs by targeting “local-from-local” production, according to Claus Rettig, President Asia Pacific at the German-based specialty chemicals firm.
Evonik is undergoing a significant strategic transformation, aiming to increase its adjusted earnings before interest, tax, depreciation and amortization (EBITDA) by €1 billion to €2.7 billion by 2027 from €1.7 billion in 2023, Rettig told ICIS.
Published by: www.icis.com
Jonathan Yee
29-Aug-2025
